ClinicalTrials.Veeva

Menu

The Effect of Laparoscopic Splenectomy on the Immune Function for Cirrhosis Patients (ELSI)

N

Northern Jiangsu People's Hospital

Status

Completed

Conditions

Splenectomy; Status
Cirrhosis, Liver

Treatments

Procedure: Laparoscopic splenectomy

Study type

Interventional

Funder types

Other

Identifiers

NCT05339269
YZUC-010

Details and patient eligibility

About

In this study, the investigators compared the improvement of and azygoportal disconnection related indicators in patients with liver cirrhosis after laparoscopic splenectomy. To determine whether surgical treatment can help enhance postoperative immune function and improve patient prognosis.

Full description

The patients were enrolled according to the research criteria, and collected the general basic information of the patients. After the preoperative preparation was perfected, the same surgical team performed laparoscopic splenectomy, and the same nursing team performed the nursing after the operation. Then, patients received a unified treatment plan after surgery, including medication, other treatments and follow-up. During the treatment, the immune function related indicators of the patients were monitored before surgery, 3, 6, 12 and 24 months after surgery, including the counts of leukocytes, neutrophils, lymphocytes, and monocytes, and the levels of CD4+, CD8+, CD4+/CD8+, and CD19, CD20.

Enrollment

21 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • A clinical, radiological or histologic diagnosis of cirrhosis of any etiology
  • Splenomegaly with secondary hypersplenism, Platelet count < 50*10^9/L
  • Informed consent to participate in the study

Exclusion criteria

  • Hepatocellular carcinoma or any other malignancy,
  • Child-Pugh grade C
  • Recent peptic ulcer disease
  • History of Hemorrhagic stroke
  • Pregnancy.
  • Uncontrolled Hypertension
  • Bleeding portal hypertension
  • Human immunodeficiency virus (HIV) infection

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

21 participants in 1 patient group

Laparoscopic splenectomy
Experimental group
Description:
The laparoscopic splenectomy is performed by the same surgical team.
Treatment:
Procedure: Laparoscopic splenectomy

Trial contacts and locations

1

Loading...

Central trial contact

Guo-Qing Jiang, MD; Dou-Sheng Bai, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems